| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
DiaMedica Therapeutics Inc.
13G/A
DMAC · 25253X207
|
16.9% |
2/6/2026
Event 12/31/2025
|
||||
| Trill AB | 16.9% | |||||
| Jan Stahlberg | 16.9% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.